Maximum quantity allowed is 999
CAS RN: 15042-01-0 | Product Number: I0507
(+)-5,6-O-Isopropylidene-L-ascorbic Acid
Purity: >98.0%(T)(HPLC)
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
5G |
₹5,300.00
|
Contact Us | 28 |
|
25G |
₹22,800.00
|
Contact Us | 23 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | I0507 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__9H__1__2O__6 = 216.19 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
Store Under Inert Gas | Store under inert gas |
Condition to Avoid | Moisture Sensitive |
CAS RN | 15042-01-0 |
Reaxys Registry Number | 86893 |
PubChem Substance ID | 87571856 |
MDL Number | MFCD00010552 |
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Iodometric Titration) | min. 98.0 % |
Specific rotation [a]20/D | +8.0 to +12.0 deg(C=5, Methanol) |
Solubility in Methanol | almost transparency |
Melting Point | 210 °C |
Specific Rotation | 10° (C=5,MeOH) |
References
- Synthesis of fatty acid metabolites
- Synthesis of (2S,3S)-1,2-O-isopropylidenebutane-1,2,3-triol
- Synthesis of (R)-1,2-O-isopropylidenebutane-1,2,4-triol
- Synthesis of biologically active (R)-γ-amino-β-hydroxybutyric acid
- Synthesis of chiral β-lactams
- Synthesis of chiral β-hydroxy-γ-lactones
- Synthesis of chiral 2,3-O-isopropylidene-L-glyceric acid
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.